Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ACP1 | P24666 | 1/20 | 0.38 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.38 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL9860417 | 0.90 | SRC (0.46) | SRCALDH1A1LMNAKDM4EGMNN | |
| SCHEMBL31595905 | 0.87 | ACP3 (0.46) | SRCALDH1A1 | |
| SCHEMBL4130950 | 0.80 | SRC (0.41) | SRCALDH1A1TSHRLMNACYP2D6 | |
| SCHEMBL438263 | 0.78 | SRC (0.40) | SRCALDH1A1TSHRLMNACYP2D6 | |
| SCHEMBL9006009 | 0.76 | CA1 (0.42) | SRCALDH1A1 | |
| SCHEMBL5555043 | 0.76 | SRC (0.39) | SRCALDH1A1TSHRLMNACYP2D6 | |
| SCHEMBL5555050 | 0.76 | SRC (0.39) | SRCALDH1A1TSHRLMNAKDM4E | |
| SCHEMBL3633092 | 0.76 | ALDH1A1 (0.42) | SRCALDH1A1TSHRLMNATDP1 | |
| SCHEMBL153281 | 0.75 | SRC (0.58) | SRCALDH1A1TSHRSMN1; SMN2LMNA | |
| SCHEMBL496890 | 0.75 | SRC (0.58) | SRCALDH1A1TSHRSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113773572-A | Preparation method of modified biological calcium carbonate EVA environment-friendly sole | 茂泰(福建)鞋材有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-110903480-A | Preparation method of controllable molecular weight polysulfone | 万华化学集团股份有限公司 | 2020-03-24 | — | — | CN | claimed |
| CN-113461817-B | Anti-human CD47 antibody and antigen binding fragment thereof, preparation method and application | 苏州泽璟生物制药股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-118389514-A | TRF related to breast cancer combined diabetes and application thereof | 深圳大学 | 2024-07-26 | — | — | CN | disclosed |
| CN-113906052-B | anti-CEACAM 5 monoclonal antibody, preparation method and application thereof | 普米斯生物技术(珠海)有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-113773572-B | Preparation method of modified biological calcium carbonate EVA environment-friendly sole | 茂泰(福建)新材料科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-113474372-B | anti-CEACAM 5 monoclonal antibody, preparation method and application thereof | 上海吉倍生物技术有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-113444180-B | Antibody targeting AXL protein, antigen binding fragment thereof, preparation method and application thereof | 上海鑫湾生物科技有限公司 | 2023-03-31 | — | — | CN | disclosed |
| WO-2022261846-A1 | ANTIBODY TARGETING AXL PROTEIN AND ANTIGEN BINDING FRAGMENT THEREOF, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海鑫湾生物科技有限公司 | 2022-12-22 | — | — | WO | disclosed |
| CN-111234017-B | Anti-human PD-L1 antibody and antigen binding fragment thereof, preparation method and application | 优迈生物科技(连云港)有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-114634577-A | Fusion protein and application thereof in preparing medicine for treating tumor and virus infection | 南京优迈生物科技有限公司 | 2022-06-17 | — | — | CN | disclosed |
| EP-0587311-A1 | Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
| EP-0498680-A1 | New beta-amino-alpha-hydroxycarboxylic acids and their use | Sankyo Company Limited (JP) | 1992-08-12 | — | — | EP | disclosed |
| EP-0174704-B1 | COMPOSITION FOR PROTECTING TEETH AGAINST DECALCIFICATION | Stichting Biomaterials Science Center, VU, "BSC-VU" (NL) | 1989-01-11 | — | — | EP | disclosed |
| EP-0189275-A2 | Method for manufacture of fluorine-containing aromatic derivatives | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1986-07-30 | — | — | EP | disclosed |
| EP-0174704-A2 | Composition for protecting teeth against decalcification | Stichting Biomaterials Science Center, VU, "BSC-VU" (NL) | 1986-03-19 | — | — | EP | disclosed |
| US-4267361-A | HYPOTENSIVE, ANTIULCER, AND BRONCHODILATOR AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| US-4254278-A | BRONCHODILATORS, ANTIULCER, HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-03-03 | — | — | US | disclosed |
| US-4060549-A | Process for preparing sulfonic acid fluorides | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-29 | — | — | US | disclosed |
| US-4009085-A | ELECTRODEPOSITION OF CHROMIUM OXIDE | M & T CHEMICALS INC. (US) | 1977-02-22 | — | — | US | disclosed |